Pablo Garcia-Cabezudo
Malaga, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Pre-infusion quantitative EEG features associated with delayed neurocognitive impairment following CAR T-cell therapy.
Journal: Journal of neuroimmunology
Published: December 15, 2025
Long-term Impact of Cenobamate on Cognition in Patients with Drug-Resistant Focal Epilepsy: Outcomes from an Exploratory Real-World Study.
Journal: Neurology and therapy
Published: September 15, 2025
Impact of TNF inhibitors on inflammation-associated cognitive dysfunction in patients with rheumatoid arthritis: a prospective analysis.
Journal: Frontiers in medicine
Published: January 15, 2025
Advances and guidance in the treatment of drug-resistant epilepsy: a review by the Andalusian Epilepsy Society of the new drugs cenobamate, fenfluramine and cannabidiol
Journal: Revista de neurologia
Published: September 13, 2024
A Systematic Review of the Predictive and Diagnostic Uses of Neuroinflammation Biomarkers for Epileptogenesis.
Journal: International journal of molecular sciences
Published: May 22, 2024
Interstitial Lung Disease Is Associated with Sleep Disorders in Rheumatoid Arthritis Patients.
Journal: Clocks & sleep
Published: October 08, 2023
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: March 31, 2023
Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program.
Journal: Epilepsia open
Published: March 17, 2023
Epileptic and neurodevelopmental encephalopathy associated to SYNGAP1 mutation: Description of a case and treatment response to cannabidiol.
Journal: Neurologia
Published: September 24, 2022
Last Updated: 09/26/2026